A 2023 meta-analysis reported a reduction in postprandial blood glucose following supplementation with resistant starch types 1 and 2, and a decrease in postprandial insulin response with resistant starch type 2 (RS2) in patients with T2DM or prediabetes [53]. Here, INS is linked to type 2 diabetes mellitus.